Effect of Extract of Urtica dioica on perennial Allergic Rhinitis
Phase 2
- Conditions
- Allergic Rhinitis.Other allergic rhinitis
- Registration Number
- IRCT2013102715177N1
- Lead Sponsor
- Vice Chancellor for Research, Mashhad University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Clinical and laboratory diagnosis perennial allergic rhinitis; Patients' willingness to participate in treatment and plan
Exclusion criteria:
The risk of other causes of rhinitis; Systemic diseases such as polycythemia; Use of other drugs with anti-inflammatory properties;Use of any herbal remedy; Intolerance of side effects urtica dioica; Drug use weak immune system; Use of antidiabetic drugs; Use of hypertensive drugs; Pregnancy & Breastfeeding; Age less than 15 years and more than 45 years.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms of Allergic rhinitis. Timepoint: Befor and after treatment. Method of measurement: SNOT - 22.
- Secondary Outcome Measures
Name Time Method Blood level of IgE. Timepoint: Before and after treatment. Method of measurement: ELISA.;Blood level of IL5. Timepoint: Before and after treatment. Method of measurement: ELISA.;Blood level of IL4. Timepoint: Before and after treatment. Method of measurement: ELISA.;Blood level of INF Gamma. Timepoint: Before and after treatment. Method of measurement: ELISA.;Nasal eosinophil count. Timepoint: Before and after treatment. Method of measurement: Eosinophil count.